Annual Cost Of Goods Sold
$10.66 B
-$1.17 B-9.92%
31 December 2023
Summary:
GSK annual cost of goods sold is currently $10.66 billion, with the most recent change of -$1.17 billion (-9.92%) on 31 December 2023. During the last 3 years, it has risen by +$481.11 million (+4.73%). GSK annual cost of goods sold is now -29.64% below its all-time high of $15.15 billion, reached on 31 December 2019.GSK Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cost Of Goods Sold
$3.12 B
+$441.73 M+16.50%
30 September 2024
Summary:
GSK quarterly cost of goods sold is currently $3.12 billion, with the most recent change of +$441.73 million (+16.50%) on 30 September 2024. Over the past year, it has increased by +$242.10 million (+8.42%). GSK quarterly cost of goods sold is now -59.75% below its all-time high of $7.75 billion, reached on 31 December 2003.GSK Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Cost Of Goods Sold
$11.30 B
+$242.10 M+2.19%
30 September 2024
Summary:
GSK TTM cost of goods sold is currently $11.30 billion, with the most recent change of +$242.10 million (+2.19%) on 30 September 2024. Over the past year, it has increased by +$1.01 billion (+9.81%). GSK TTM cost of goods sold is now -27.91% below its all-time high of $15.67 billion, reached on 31 March 2020.GSK TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.9% | +8.4% | +9.8% |
| 3 y3 years | +4.7% | +12.2% | +45.1% |
| 5 y5 years | -22.0% | -22.0% | -23.1% |
GSK Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -9.9% | +4.7% | -16.9% | +32.1% | -13.0% | +45.1% |
| 5 y | 5 years | -29.6% | +4.7% | -25.5% | +491.4% | -27.9% | +45.1% |
| alltime | all time | -29.6% | +646.9% | -59.8% | +189.2% | -27.9% | +2228.9% |
GSK Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.12 B(+16.5%) | $11.30 B(+2.2%) |
| June 2024 | - | $2.68 B(+7.1%) | $11.06 B(+2.4%) |
| Mar 2024 | - | $2.50 B(-16.8%) | $10.80 B(+1.3%) |
| Dec 2023 | $10.66 B(-9.9%) | $3.00 B(+4.4%) | $10.66 B(+3.6%) |
| Sept 2023 | - | $2.88 B(+19.0%) | $10.29 B(+0.2%) |
| June 2023 | - | $2.42 B(+2.4%) | $10.26 B(-3.0%) |
| Mar 2023 | - | $2.36 B(-10.3%) | $10.58 B(-10.8%) |
| Dec 2022 | $11.83 B(+5.4%) | $2.63 B(-7.7%) | $11.86 B(-8.6%) |
| Sept 2022 | - | $2.85 B(+4.2%) | $12.99 B(+0.6%) |
| June 2022 | - | $2.74 B(-25.0%) | $12.91 B(+2.8%) |
| Mar 2022 | - | $3.65 B(-2.9%) | $12.57 B(+1.8%) |
| Dec 2021 | $11.23 B(+10.4%) | $3.75 B(+35.1%) | $12.34 B(+58.4%) |
| Sept 2021 | - | $2.78 B(+16.4%) | $7.79 B(-10.9%) |
| June 2021 | - | $2.39 B(-30.2%) | $8.74 B(-6.9%) |
| Mar 2021 | - | $3.42 B(-529.0%) | $9.39 B(-6.8%) |
| Dec 2020 | $10.18 B(-32.8%) | -$796.94 M(-121.4%) | $10.07 B(-33.1%) |
| Sept 2020 | - | $3.73 B(+22.8%) | $15.05 B(-1.8%) |
| June 2020 | - | $3.04 B(-25.9%) | $15.32 B(-2.2%) |
| Mar 2020 | - | $4.10 B(-2.0%) | $15.67 B(+3.6%) |
| Dec 2019 | $15.15 B(+10.9%) | $4.18 B(+4.6%) | $15.13 B(+3.1%) |
| Sept 2019 | - | $4.00 B(+18.0%) | $14.68 B(+4.0%) |
| June 2019 | - | $3.39 B(-4.8%) | $14.12 B(+1.7%) |
| Mar 2019 | - | $3.56 B(-4.7%) | $13.88 B(+1.7%) |
| Dec 2018 | $13.66 B(+2.3%) | $3.74 B(+8.8%) | $13.64 B(+2.6%) |
| Sept 2018 | - | $3.43 B(+9.1%) | $13.30 B(-0.3%) |
| June 2018 | - | $3.15 B(-5.3%) | $13.34 B(-1.5%) |
| Mar 2018 | - | $3.32 B(-2.1%) | $13.54 B(+1.6%) |
| Dec 2017 | $13.35 B(+6.1%) | $3.40 B(-2.2%) | $13.33 B(+2.2%) |
| Sept 2017 | - | $3.47 B(+3.7%) | $13.05 B(+1.2%) |
| June 2017 | - | $3.35 B(+7.6%) | $12.89 B(+2.4%) |
| Mar 2017 | - | $3.11 B(-0.1%) | $12.60 B(+0.5%) |
| Dec 2016 | $12.59 B(-7.0%) | $3.12 B(-6.1%) | $12.54 B(-5.6%) |
| Sept 2016 | - | $3.32 B(+8.7%) | $13.28 B(-0.7%) |
| June 2016 | - | $3.05 B(-0.1%) | $13.37 B(-0.2%) |
| Mar 2016 | - | $3.05 B(-20.8%) | $13.39 B(-1.0%) |
| Dec 2015 | $13.53 B(+12.1%) | $3.85 B(+12.9%) | $13.53 B(+5.0%) |
| Sept 2015 | - | $3.42 B(+11.2%) | $12.88 B(+2.9%) |
| June 2015 | - | $3.07 B(-3.7%) | $12.52 B(+1.4%) |
| Mar 2015 | - | $3.19 B(-0.7%) | $12.35 B(+2.5%) |
| Dec 2014 | $12.07 B(-10.1%) | $3.21 B(+5.1%) | $12.05 B(-6.8%) |
| Sept 2014 | - | $3.05 B(+5.4%) | $12.92 B(-1.7%) |
| June 2014 | - | $2.90 B(+0.5%) | $13.14 B(-1.0%) |
| Mar 2014 | - | $2.88 B(-29.5%) | $13.28 B(-1.4%) |
| Dec 2013 | $13.43 B(+7.0%) | $4.09 B(+24.9%) | $13.46 B(+6.7%) |
| Sept 2013 | - | $3.27 B(+8.1%) | $12.61 B(-0.2%) |
| June 2013 | - | $3.03 B(-1.3%) | $12.64 B(-1.1%) |
| Mar 2013 | - | $3.07 B(-5.2%) | $12.77 B(+1.7%) |
| Dec 2012 | $12.56 B(+2.4%) | $3.24 B(-1.8%) | $12.56 B(+1.4%) |
| Sept 2012 | - | $3.30 B(+4.2%) | $12.38 B(-0.4%) |
| June 2012 | - | $3.17 B(+10.9%) | $12.44 B(+2.6%) |
| Mar 2012 | - | $2.86 B(-6.8%) | $12.12 B(-1.2%) |
| Dec 2011 | $12.26 B | $3.06 B(-8.7%) | $12.26 B(-5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $3.35 B(+17.9%) | $12.96 B(+3.2%) |
| June 2011 | - | $2.85 B(-5.1%) | $12.56 B(+3.1%) |
| Mar 2011 | - | $3.00 B(-20.3%) | $12.19 B(-0.4%) |
| Dec 2010 | $12.18 B(+5.3%) | $3.76 B(+27.5%) | $12.23 B(+2.5%) |
| Sept 2010 | - | $2.95 B(+19.5%) | $11.93 B(+0.2%) |
| June 2010 | - | $2.47 B(-18.9%) | $11.90 B(-1.3%) |
| Mar 2010 | - | $3.04 B(-12.1%) | $12.06 B(+4.1%) |
| Dec 2009 | $11.56 B(-2.6%) | $3.46 B(+18.4%) | $11.58 B(+3.6%) |
| Sept 2009 | - | $2.92 B(+11.2%) | $11.18 B(-0.7%) |
| June 2009 | - | $2.63 B(+2.3%) | $11.26 B(-3.1%) |
| Mar 2009 | - | $2.57 B(-16.0%) | $11.61 B(-1.0%) |
| Dec 2008 | $11.86 B(+13.8%) | $3.06 B(+1.7%) | $11.73 B(-0.7%) |
| Sept 2008 | - | $3.01 B(+0.8%) | $11.81 B(+4.6%) |
| June 2008 | - | $2.98 B(+11.0%) | $11.29 B(+5.4%) |
| Mar 2008 | - | $2.69 B(-14.2%) | $10.72 B(+2.6%) |
| Dec 2007 | $10.43 B(+12.9%) | $3.13 B(+25.8%) | $10.44 B(+3.6%) |
| Sept 2007 | - | $2.49 B(+3.5%) | $10.08 B(+2.0%) |
| June 2007 | - | $2.41 B(-0.2%) | $9.88 B(+2.0%) |
| Mar 2007 | - | $2.41 B(-12.9%) | $9.68 B(+4.6%) |
| Dec 2006 | $9.23 B(+6.6%) | $2.77 B(+20.9%) | $9.26 B(+5.7%) |
| Sept 2006 | - | $2.29 B(+3.5%) | $8.76 B(+2.0%) |
| June 2006 | - | $2.21 B(+11.4%) | $8.58 B(+0.8%) |
| Mar 2006 | - | $1.99 B(-12.4%) | $8.51 B(-1.7%) |
| Dec 2005 | $8.67 B(+8.5%) | $2.27 B(+7.0%) | $8.66 B(+0.9%) |
| Sept 2005 | - | $2.12 B(-1.0%) | $8.58 B(+1.3%) |
| June 2005 | - | $2.14 B(+0.4%) | $8.48 B(+3.1%) |
| Mar 2005 | - | $2.13 B(-2.8%) | $8.22 B(+2.9%) |
| Dec 2004 | $7.99 B(+7.6%) | $2.19 B(+9.0%) | $7.99 B(-41.0%) |
| Sept 2004 | - | $2.01 B(+6.7%) | $13.55 B(+68.5%) |
| June 2004 | - | $1.89 B(-0.8%) | $8.04 B(+2.3%) |
| Mar 2004 | - | $1.90 B(-75.5%) | $7.86 B(+1.3%) |
| Dec 2003 | $7.42 B(+7.1%) | $7.75 B(-321.6%) | $7.76 B(+292.1%) |
| Sept 2003 | - | -$3.50 B(-304.9%) | $1.98 B(-72.6%) |
| June 2003 | - | $1.71 B(-5.1%) | $7.22 B(+1.2%) |
| Mar 2003 | - | $1.80 B(-8.7%) | $7.14 B(+3.0%) |
| Dec 2002 | $6.93 B(+8.3%) | $1.97 B(+12.6%) | $6.94 B(+5.1%) |
| Sept 2002 | - | $1.75 B(+7.8%) | $6.60 B(+1.5%) |
| June 2002 | - | $1.62 B(+1.9%) | $6.50 B(+0.7%) |
| Mar 2002 | - | $1.59 B(-2.5%) | $6.46 B(+1.1%) |
| Dec 2001 | $6.39 B(+6.5%) | $1.63 B(-1.2%) | $6.39 B(-0.2%) |
| Sept 2001 | - | $1.65 B(+4.7%) | $6.41 B(+4.2%) |
| June 2001 | - | $1.58 B(+3.6%) | $6.15 B(+0.4%) |
| Mar 2001 | - | $1.53 B(-7.3%) | $6.12 B(+2.3%) |
| Dec 2000 | $6.01 B(-14.4%) | $1.65 B(+18.1%) | $5.99 B(+37.9%) |
| Sept 2000 | - | $1.39 B(-10.4%) | $4.34 B(+47.3%) |
| June 2000 | - | $1.56 B(+11.9%) | $2.95 B(+53.4%) |
| Mar 2000 | - | $1.39 B(+162.0%) | $1.92 B(+262.0%) |
| Dec 1999 | $7.01 B(+173.9%) | - | - |
| June 1999 | - | $530.79 M(+9.4%) | $530.79 M(+9.4%) |
| Dec 1998 | $2.56 B(+79.5%) | - | - |
| June 1998 | - | $485.13 M | $485.13 M |
| June 1995 | $1.43 B | - | - |
FAQ
- What is GSK annual cost of goods sold?
- What is the all time high annual cost of goods sold for GSK?
- What is GSK annual cost of goods sold year-on-year change?
- What is GSK quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for GSK?
- What is GSK quarterly cost of goods sold year-on-year change?
- What is GSK TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for GSK?
- What is GSK TTM cost of goods sold year-on-year change?
What is GSK annual cost of goods sold?
The current annual cost of goods sold of GSK is $10.66 B
What is the all time high annual cost of goods sold for GSK?
GSK all-time high annual cost of goods sold is $15.15 B
What is GSK annual cost of goods sold year-on-year change?
Over the past year, GSK annual cost of goods sold has changed by -$1.17 B (-9.92%)
What is GSK quarterly cost of goods sold?
The current quarterly cost of goods sold of GSK is $3.12 B
What is the all time high quarterly cost of goods sold for GSK?
GSK all-time high quarterly cost of goods sold is $7.75 B
What is GSK quarterly cost of goods sold year-on-year change?
Over the past year, GSK quarterly cost of goods sold has changed by +$242.10 M (+8.42%)
What is GSK TTM cost of goods sold?
The current TTM cost of goods sold of GSK is $11.30 B
What is the all time high TTM cost of goods sold for GSK?
GSK all-time high TTM cost of goods sold is $15.67 B
What is GSK TTM cost of goods sold year-on-year change?
Over the past year, GSK TTM cost of goods sold has changed by +$1.01 B (+9.81%)